s u m m a r y Objective: Recently it was shown that loading of articular cartilage explants activates TGFb signaling. Here we investigated if in vivo chondrocytes express permanently high TGFb signaling, and the consequence of the loss of compressive loading-mediated TGFb signaling on chondrocyte function and phenotype. Method: Bovine articular cartilage explants were collected within 10 min post mortem and stained immediately and after 30, 60 and 360 min for phosphorylated-Smad2, indicating active TGFb signaling. Explants were unloaded for 48 h and subsequently repeatedly loaded with a compressive load of 3 MPa. In addition, explants were cultured unloaded for 2 weeks and the effect of loading or exogenous TGFb on proteoglycan level and chondrocyte phenotype (Col10a1 mRNA expression) was analyzed. Results: Unloading of articular cartilage results in rapid loss of TGFb signaling while subsequent compressive loading swiftly restored this. Loading and exogenous TGFb enhanced expression of TGFb1 and ALK5. Unloading of explants for 2 weeks resulted in proteoglycan loss and increased Col10a1 expression. Both loading and exogenous TGFb inhibited elevated Col10a1 expression but not proteoglycan loss. Conclusion: Our data might imply that in vivo regular physiological loading of articular cartilage leads to enduring TGFb signaling and TGFb-induced gene expression. We propose a hypothetical model in which loading activates a self-perpetuating system that prevents hypertrophic differentiation of chondrocytes and is crucial for cartilage homeostasis.
Introduction
Loading of articular cartilage is absolutely essential for its maintenance. Reduced joint loading leads to cartilage atrophy and degeneration, both in humans and animal models 1e5 . Patients with spinal cord injuries show progressive loss of knee cartilage at a pace faster than osteoarthritis (OA) patients 6, 7 . In dogs it has been shown that joint motion in the absence of normal loading is not sufficient to prevent this cartilage loss 8 . Moreover, articular chondrocytes are mechanosensitive cells which has been clearly described in a number of excellent recent reviews 9e11 . However, the exact mechanism how unloading negatively affects articular cartilage homeostasis has not been elucidated yet.
Transforming growth factor-b (TGFb) is stored in high amounts (up to~300 ng/g of all isoforms) in the articular cartilage matrix but in a latent form 12 . TGFb signaling has been shown to be essential for the preservation of articular cartilage. Loss of the intracellular TGFb signaling molecule Smad3 or functional loss of the TGFb type II receptor in chondrocytes results in loss of articular cartilage in mice 13e15 . In humans, an inactivating mutation of Smad3 results in early onset of OA while a Smad3 polymorphism is associated with the total burden of radiographic OA 16e18 . It has been shown that mechanical stimulation can activate TGFb signaling in chondrocyte-like cells 19, 20 . Recently, we described that compressive in vitro loading of bovine articular cartilage explants rapidly induces TGFb signaling 21 . Based on these observations we hypothesized that under normal in vivo conditions articular cartilage is always subject to active TGFb signaling and that loss of in vivo loading will result in loss of signaling. Remarkably, this has never been investigated yet. In this study it was investigated if TGFb signaling was lost when articular cartilage was taken out of its natural environment and if the changes in TGFb signaling could be reversed by in vitro compressive loading. Moreover, we studied the effect of prolonged unloading in vitro on proteoglycan content and chondrocyte phenotype, as measured by expression of Col10a1, and if induced changes could be prevented by loading or exogenously added TGFb. Our data indicate that unloading results in rapid loss of TGFb signaling and this might lead to changes in chondrocyte phenotype. Based on our observations a self-regulatory loading-driven model is proposed that keeps articular cartilage healthy, connecting compressive loading to cartilage homeostasis via TGFb.
Material and methods
For all performed experiments full cartilage thickness explants were harvested from bovine metacarpophalangeal joints (MCP) of skeletally mature cows (age-4e5 years old) obtained from the local abattoir. 0.7 ± 0.12 mm thick explants were isolated with a 4 mm Ø biopsy punch (Kai-medical, Japan). All explants (if cultured) were cultured in standard culture conditions (37 C, 5% CO 2 and 95% humidity) in DMEM/F-12 medium (Gibco ® , UK) containing Antibiotic-Antimycotic (contains 10,000 units/mL of penicillin, 10,000 mg/mL of streptomycin, and 25 mg/mL of Fungizone Bovine articular cartilage explants were harvested from the MCP joint of skeletally mature cows (age 3e5 years old). Joints were processed within 10 min post mortem (joint loading stopped).
For immunohistochemical (IHC) analysis, explants (4 mm Ø) were fixed in 4% phosphate buffered formalin (pH 7.0) directly after isolation or first cultured for 30 min, 2 h, 6 h or 24 h at standard culture conditions in DMEM/F-12 medium (Gibco ® , UK). No serum was added to the medium. For gene expression analysis, explants were isolated within 3 h post mortem. One group of explants was flash frozen in liquid nitrogen immediately after opening. The remaining groups were placed in medium with or without the ALK4/5/7 kinase blocker SB-505124 (SigmaeAldrich, St. Louis, MO, USA) 22 (5 mM) or vehicle control (0.5 ml/ml Dimethyl sulfoxide (DMSO)) for 24 or 48 h. This experiment was repeated in seven animals.
Effect of repeated physiological mechanical compression on TGFb signaling in articular cartilage [ Fig. 1 
(B)]
Five groups were used in this experiment [see Fig. 1(B) ]. Explants were harvested within 3 h post mortem. After 48 h of equilibration, the first group of explants was frozen, whereas the other groups of explants were subjected to 3 MPa dynamic mechanical compression for 30 min with a frequency of 1 Hz
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[ Fig. 1(B) ]. At 2 h after the first compression, a second group of explants was frozen. The remaining groups of explants were again cultured for 48 h after which the third group of explants was frozen. At the same day the last two groups of explants were subjected to mechanical compression. Two hours after the second compression, the fourth group of explants was frozen and the fifth group was further cultured for 48 h and then frozen.
The same experimental set up was repeated in the presence of SB-505124 (5 mM) or DMSO. The specimens were pre-incubated with SB-505124 (or DMSO) for 1 h prior to the compression to ensure penetration of the agent 21 . SB-505124 or DMSO was also present in the medium during and after dynamic mechanical compression. These experiments were repeated four times.
To immunohistochemically investigate the induction of pSmad2 by mechanical compression after 48 h of equilibration, explants The first group of explants was isolated and flash frozen immediately after joint opening. After an equilibrium period of 48 h the medium of four other groups was changed for DMEM/F-12 containing 10 % Fetal Bovine Serum, 20 ng/ml of rhIGF-1 (PeproTech, NJ, USA) or 10 ng/ml rhTGFb1 (Biolegend, CA, USA) or combination of 20 ng/ml of rhIGF-1 þ 10 ng/ml rhTGFb1 and refreshed every 72 h. An additional group of explants was subjected to mechanical compression every 48 h for 14 days. At day 14, explants from all groups were flash frozen and GAG content was measured using Dimethylmethylene Blue (DMB).
To analyze if a lack of mechanical load on articular cartilage explants results in induction of Col10a1 a first group of explants was isolated and immediately frozen. Four other groups were cultured in unloaded condition for 14 days in DMEM/F-12 medium supplemented with 10 % FBS or 1 ng/ml rhTGFb1 or 10 ng/ml rhTGFb1 or 50 ng/ml of Activin A (R&D Systems, MN, USA). To investigate if mechanical compression is able to inhibit non-loading induced induction of Col10a1 expression an extra group of explants was subjected to mechanical compression three times during the first week of the experiment (every 72 h). During the second week of the experiment, only medium was changed every 72 h. This experiment was conducted 6 times.
Dynamic mechanical compression of articular cartilage explants
To compress cartilage, a BOSE ® ElectroForce ® BioDynamicTM bioreactor (5160 BioDynamic System) equipped with a 50 lbf loadcell was used (BOSE Bose Corp. ElectroForce Systems Group, MN, USA). First, a preset compression force of 5 N (0.3 MPa) was applied to guarantee contact between plates and specimen. Subsequently, explants were subjected to 3 MPa, force controlled, unconfined, dynamic mechanical compression using a 1 Hz sine wave and desired pressure for 30 min (1800 cycles). Unloaded controls were also placed in the bioreactor incubator but in a separate well.
Gene expression analysis
Samples were homogenized using a micro dismembrator (B. Braun Biotech International, Melsungen, Germany). Total RNA was isolated using RNeasy Fibrous tissue kits (Qiagen Inc., Valenzia, CA, USA) according to manufacturers protocol. Isolated RNA was transcribed into cDNA using M-MLV reverse transcriptase and single step RT-PCR: 5 min at 25 C, 60 min at 39 C, and 5 min at 95 C. Gene expression was measured using 0.5 mM of validated primers (see Table I ) (Biolegio, the Netherlands) in a quantitative real time polymerase chain reaction (qPCR) using SYBR green (Applied Biosystems, Darmstadt, Germany). A melting curve was made to verify gene specific amplification. Two reference genes were used: glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and ribosomal protein S14 (RPS14).
IHC analysis
Samples were fixed overnight in phosphate buffered formalin, dehydrated and embedded in paraffin. Six mm thick sections were cut and mounted on Superfrost™ Plus Microscope Slides (Thermo Scientific, Waltham, USA). After deparaffinization, citrate buffer (0.1 M sodium citrate and 0.1 M citric acid) was used for 2 h at RT for antigen unmasking. Hydrogen peroxide 1% v/v in methanol was used for 30 min to block endogenous peroxidase. Afterwards, sections were incubated overnight at 4 C with specific primary antibodies against c-terminally phosphorylated SMAD2P (rabbit pAb anti Phospho-Smad2 (Ser465/467) (1:100) (Cell Signalling Technology, Danvers, Massachusetts, USA). Biotin-labelled secondary antibodies were used (Dako, Glostrup, Denmark). Together with a biotinestreptavidin detection system used according to the manufacturers' protocol (Vector Laboratories, Baiklin Game, California, USA). Staining was visualized using dimethylaminoazobenzene (DAB) reagent 23 .
Spectrophotometric analysis
Cartilage explants were weighed and digested overnight at 60 C using papain (1 mg/ml papain, 0.1 M sodium acetate, 10 mM Lcysteine hydrochloride and 50 mM ethylenediaminetetraacetic acid sodium salt, pH 6.0). After digestion, samples were centrifuged for 15 min at 15,000 RPM and supernatant was diluted 20 times in ultra pure water. 200 ml of the DMB solution was added to 40 ml of diluted digest, and absorbance at l ¼ 595 nm was measured immediately using a 96-well plate reader (Biorad, CA, USA).
Statistical analysis
All quantitative data analysis were expressed as a Tukey box blot with mean showed as "þ" and outliers showed as "". All datasets were checked for normality using the ShapiroeWilk's test and then for equality of variances by Levene's test.
Linear mixed models with Bonferroni multiple comparison post tests were used to estimate the effect of time and treatment (þDMSO or þ SB-505124) on gene expression levels. One way ANOVA with Fisher's LSD post-test was used to estimate the effect of compression or the effect of lack of the compression on gene expression (LSD does not correct for multiple comparisons, however we compared only the effect of the compression on induction of the gene expression or the effect of lack of the compression on gene drop, no multiple comparisons were required). The same approach was used to estimate the effect of compression or lack of the compression and treatment (þDMSO or þSB-505124) on Smad7 expression levels. One way ANOVA with Tukey's post-test was used to estimate the effect of treatments on GAG content. The same approach was used to estimate the effect of treatments on bCol10a1 gene expression. Unpaired one tailed t-test was used to estimate the effect of time on Pai1 expression levels. One way ANOVA with Tukey's post-test was used to estimate the effect of addition of TGFb1 or Activin A on Smad7, Pai1 and Tgfb1 expression levels. The same approach was used to estimate the effect of dynamic mechanical compression on the expression levels of Alk1.
All the analyses were performed with the statistical software packages: SPSS 20.0 (SPSS, Chicago, USA).
Results

Unloading results in loss of TGFb signaling
To investigate if unloading results in loss of TGFb signaling, articular cartilage was obtained within 10 min post mortem from the MCP joint of mature cows and fixed immediately or after in vitro incubation. At the earliest time points, the majority of chondrocytes clearly stained positive for active TGFb signaling (phosphorylatedSmad2, Smad2P) throughout all zones of the articular cartilage [ Fig. 2(A) ]. However, already after 2 h of unloaded culture, cells in middle zone of the cartilage had lost staining which was even more pronounced after 6 h. At 6 and 24 h only very few cells stained positive for Smad2P. To ensure that this loss in Smad2P staining was not a cutting artifact we left intact MCP joints unopened for 6 h or overnight and thereafter isolated the cartilage. After 6 h, cartilage had highly reduced Smad2P staining. Moreover, cartilage stored overnight showed significantly reduced Pai1 (a marker for active TGFb signaling) expression when compared to fresh tissue ( Supplementary Fig. 2 ).
To determine whether this rapid drop in Smad2/3 signaling was reflected in TGFb signaling-dependent gene expression, expression of the known ALK5/Smad3 responsive genes Smad7
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, Pai1
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Alk5 (also known as TGFBR1) 26 was assessed. Expression of all three genes was significantly reduced after 24 h and further lowered after 48 h [ Fig. 2(B) ]. Addition of the ALK4/5/7 blocker SB-505124 which blocks TGFb signaling did not result in a more severe loss of gene expression, indicating that no residual TGFb signaling was present in the unloaded, cultured cartilage and that absence of loading has similar effects as actively blocking Smad2/3 signaling [ Fig. 2(C) ]. Notably, a decrease in gene expression is not a general phenomenon in unloaded cartilage, as the expression levels of for example Acan (aggrecan) and Smad3 were maintained [ Fig. 2(D) ].
Reloading repeatedly induces TGFb signaling
Next, we evaluated if compressive reloading could restore Smad2P signaling and TGFb-dependent gene expression and if this was a repeatable process. Therefore explants were loaded 48 h after isolation and again 48 h after the first in vitro loading. Compressive loading rapidly induced Smad2P staining in cartilage explants [ Fig. 3(A) ].
Two hours after the first 30 min of loading, gene expression of Alk5, Smad7 and Pai1 was significantly induced, indicating that loading restores TGFb signaling [ Fig. 3(B) ]. Strikingly, 48 h after the first in vitro loading gene expression had dropped again to unloaded levels. Two hours after a second loading for 30 min, again gene expression of Smad7 and Pai1 was strongly elevated. We could confirm our earlier observations 21 that the loading-induced expression of Smad7 can be fully blocked by the ALK4/5/7 inhibitor SB-505124 [ Fig. 3(C) ], indicating that compression-induced Smad7 expression indeed runs via active Smad2/3P. Notably, SB-505124 did not inhibit all compression-induced gene expression. For example, a loading-induced~4-fold increase in Bmp2 expression (Supplementary Fig. 3 ) was unaffected. Because Bmp2 expression was also not responsive to exogenously added TGFb, regulation of this gene is most likely TGFb-independent. This observation thus shows that SB-505124 does not affect compression-induced gene expression that is induced independently of TGFb. In Fig. 2(D) a schematic representation of the effects of loading and unloading is depicted showing the repeated mechano-responsiveness of TGFb signaling in cartilage. Finally, we were also able to confirm our earlier observations that loading reduces ALK1 expression [ Fig. 2(E) ] 21 . As a possible source for the observed induction of Smad2/3P we investigated two ligands capable of inducing these Smads: TGFb and Activin-A. Incubation of bovine explants with exogenously added TGFb resulted in comparable up-regulation of gene expression as induced by compressive loading, in contrast to Activin-A, which did not induce expression of either Alk5, Smad7 or Pai1 although it was bioactive ( Supplementary Fig. 4 ).
Loading-induced TGFb signaling blocks chondrocyte hypertrophy
Subsequently, the potential physiological relevance of the loading-induced TGFb signaling was investigated. We postulated that TGFb signaling either sustains the proteoglycan (aggrecan) content of cartilage or blocks hypertrophic differentiation of chondrocytes or both. Culturing bovine explants for 2 weeks resulted in a significant loss of glycosaminoglycans (GAGs) (nearly 60%) from the extracellular matrix (ECM). Compressive loading was totally ineffective to prevent this loss [ Fig. 4(A) ]. In contrast, this GAG loss could be prevented by addition of 10% fetal calf serum or 20 ng/ml Insulin-like Growth Factor-1 (IGF1) to the medium. However, addition of 10 ng/ml TGFb was completely ineffective and even lowered IGF1 effects on GAG content [ Fig. 4(B) ]. We conclude that it is unlikely that TGFb plays a direct role in maintenance of GAG content in articular cartilage.
Apart from GAG loss, culturing of bovine explants in the absence of loading resulted in strongly increased expression of Col10a1, an accepted marker for early hypertrophic differentiation of chondrocytes 27 . The increase in Col10a1 expression was not affected by addition of 10% fetal calf serum, underling that serum factors are not able to inhibit hypertrophic differentiation of articular chondrocytes [ Fig. 4(C) ]. In contrast, addition of 1 ng/ml TGFb fully blocked induction of Col10a1 gene expression. Of note, addition of 10 ng/ml activin did not affect the increase in Col10a1 expression. When we investigated whether compressive loading inhibited the up-regulation of Col10a1 expression, loading for 30 min at time point 48, 96 and 144 h after isolation significantly prevented the up-regulation of Col10a1 in bovine explants measured after 2 weeks [ Fig. 4(D) ]. Unfortunately, in this experimental setting, a 14 day culture period, we were unable to include the inhibitor SB-505124 because addition of this compound for such a long period resulted in significantly decreased cell viability in the cartilage explants ( Supplementary Fig. 5 ), making us unable to show the importance of Smad2/3P in this process.
Discussion
This study is the first to demonstrate that removal of articular cartilage from in its in vivo situation results in rapid loss of TGFb signaling and that subsequent compressive loading can repeatedly restore this signaling. This suggests that the absence of loading will result in the loss of TGFb signaling in articular cartilage. The consequence of this is reduced expression of TGFb1 and the TGFb type 1 receptor ALK5, together with increased expression of ALK1 21 . Fig. 4 . Dynamic mechanical compression protects against chondrocyte hypertrophy. (A) The sulfated GAG content (w/w) of adult articular cartilage, cultured for 2 weeks ex vivo either with or without 10% FCS, 10 ng/ml TGFb1 or subjected to dynamic mechanical compression (3 MPa). Tukey box plot, þ ¼ mean, N ¼ 8, ***P 0.001. (B) GAG content (w/w) of articular cartilage cultured for 2 weeks ex vivo in serum free medium, or in the presence of either: 10% FCS, 20 ng/ml IGF1, 10 ng/ml TGFb1, or a combination of IGF1 and TGFb1. Tukey box plot, N ¼ 9, *P 0.05, ***P 0.001. (C) Expression of the hypertrophy marker Col10a1 after 2 weeks ex vivo culture in serum free medium or in the presence of 10% FCS, 1 or 10 ng/ml TGFb1, or 50 ng/ml Activin A. Tukey box plot, þ ¼ mean, N ¼ 4 (for Activin A, N ¼ 2), ***P 0.001. (D) The effect of repeated dynamic mechanical compression (3 MPa) on Col10a1 expression after 2 weeks ex vivo culture. Tukey box plot, þ ¼ mean, N ¼ 6. **P 0.01, ***P 0.001.
Moreover, prolonged unloading leads to proteoglycan loss and change in chondrocyte phenotype, as determined by increased Col10a1 expression. However, compressive loading or addition of exogenous TGFb prevent the increase in Col10a1 expression but not of proteoglycan loss.
Our data demonstrate the repeated mechano-responsiveness of TGFb signaling in cartilage, which shows rapid activation upon compression and inactivation upon unloading, we propose the following hypothetical model for this loss and activation of TGFb signaling by compressive mechanical loading: Articular cartilage contains high amounts of TGFb (up to 300 ng/g 12 ), but inactive and bound to the latency-associated peptide (LAP) and ECM. LAP forms a so-called straitjacket that keeps the mature form of TGFb1 associated with LAP, but unfolding of LAP by mechanical force (40 pN) can release active TGFb 28, 29 . Mechanical force (compressive loading) is thus able to release active TGFb, and this has been shown in multiple systems 30, 31 . However, upon unloading, all active TGFb is sequestered again to the abundant binding places in the ECM 32 , inactivating it again. Although no tools are available yet to investigate this mechanism in situ in intact articular cartilage, we propose that such a mechanism explains the repeated mechanosensitivity of TGFb in cartilage.
We hypothesize that this loading-released TGFb will bind to its receptors, but will also rapidly bind the ECM becoming unavailable again 32 . In the absence of mechanical force TGFb signaling will rapidly diminish. The loading-induced TGFb signaling will induce synthesis of TGFb1 33 , but in an inactive form that will be bound to the ECM. Moreover, expression of ALK5 will be up-regulated whereas expression of ALK1 will be down-regulated, favoring TGFb-dependent Smad2/3 signaling and decreasing Smad1/5/8 signaling (Fig. 5) . Chondrocyte terminal differentiation is stimulated by Smad1/5/8 activation and inhibited the Smad2/3 34 . This is in line with our current observation that regular loading appears to prevent early hypertrophic differentiation of chondrocytes.
Other factors than TGFb will undoubtedly play a role in the mechanical regulation of articular cartilage and several mechanosensitive actors have been identified in chondrocytes 9 . For instance, compressive loading can induce BMP2 expression in cartilage 23 .
Our current study shows that loading and exogenous TGFb can block hypertrophic differentiation of chondrocytes, as measured by Col10a1 mRNA expression, but is not able to block proteoglycan loss in vitro. In vivo, proteoglycan synthesis will be maintained by systemic levels of IGF-I and BMP9 and by (load-induced) factors such as BMP2
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. The observation that the biological consequence of the loading/TGFb driven process is not the direct maintenance of proteoglycan content might appear to be in contrast with the study of Morales et al.. However, in that study cartilage of 6 months old calves was used, where growth still takes place, while cartilage from skeletally mature cows was used in our study 38 . Both TGFb and compressive loading inhibited the up-regulation of the early , but also by inducing the expression of inactive TGFb1, which after production will bind to the ECM, returning the system to its original state.
hypertrophy marker Col10a1, suggesting that loading-induced TGFb signaling blocks hypertrophic differentiation of chondrocytes in articular cartilage. Unfortunately we were not able to use SB-505124 in our long term cultures but in our short term cultures we could show that loading-induced TGFb signaling can be blocked by this inhibitor, in line with our previous work 21 . Our results are in line with earlier observations that TGFb, via the Smad2/3 signaling route, is a potent inhibitor of chondrocyte hypertrophy 13, 39, 40 .
Importantly, our results seem to indicate that loading and cartilage homeostasis are interconnected via TGFb signaling. Our study has a number of limitations. We used expression of Col10a1 as a marker for changes in chondrocyte phenotype in the direction of hypertrophy. Because we had to perform our cultures without fetal calf serum, to prevent continuous presence of TGFb, we were not able to perform our in vitro cartilage cultures endlessly. This made it impossible to demonstrate the induction of late hypertrophic markers, such as MMP13. However, although we only demonstrated elevated mRNA expression in the time span studied, we still think that our results indicate a phenotypic shift towards hypertrophy since this is supported by other studies that show that loss of TGFb signaling results in chondrocyte hypertrophy 13, 15, 17 . Another limitation is our loading regime. We use simple compressive loading as a simplified model for the mechanical forces acting in vivo on articular cartilage. The loading protocol we used results in a permanent deformation during the 30 min loading cycle of approximately 10% 23 . The force we used is in a physiological range (3 Mpa) but the loading itself will be quite different from in vivo loading. In addition, there are regions in articular cartilage which are considered non-load bearing in vivo. In our concept it should be expected that these areas deteriorate. However, it can be argued if truly non-load bearing articular cartilage exists in joints. Furthermore, these locations might experience high shear stress, which has also been shown to be able to activate TGFb
31
. Moreover, our data indicate that short physiological compressive loading once every day will be sufficient to maintain TGFb-induced gene expression. Infrequent compressive loading might be experienced by this so-called "non-loaded" cartilage but still be sufficient to maintain homeostasis.
Finally, a considerable limitation is the lack of absolute proof that the observed processes run via TGFb. SB-505124 gives an indication that an ALK4/5/7 ligand is important, but we were limited in its use due to its toxic long term effects. Unfortunately, no tools are currently available to investigate our proposed hypothesis more deeply in situ. Ideally we would knock out the TGFb type II receptor TGFBR2 41 to show the importance of TGFb in our proposed model, but we have been unable to target chondrocytes in situ with the currently available tools to manipulate gene expression. Absence of loading results in cartilage loss. Chondrocyte hypertrophy is associated with cartilage degradation and proteoglycan loss 42 . Our finding of early hypertrophic differentiation of chondrocytes in the absence of loading-induced TGFb signaling might provide an explanation for the loss of articular cartilage that is observed after long term cartilage unloading. Increased numbers of hypertrophic chondrocytes and expression of matrix degrading enzymes have been described in articular cartilage of rats after immobilization 4, 5 , which is in line with the our hypothetical model. This model, in the light of our observation that mechanicallyinduced activation of TGFb signaling is impaired in aged cartilage 23 , could be involved in the age-dependency of OA. If the hypothetical model we propose is valid, age-related loss of this loading-induced mechanism will make articular cartilage more prone to hypertrophic changes of articular chondrocytes and OA development. Furthermore, this suggests that unraveling the exact molecular mechanism underlying this system could provide tools to interfere with OA development and or progression.
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